Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Cytokinetics (CYTK)

Cytokinetics (CYTK)
41.00 x 1 44.56 x 1
Post-market by (Cboe BZX)
43.19 +0.20 (+0.47%) 03/28/25 [NASDAQ]
41.00 x 1 44.56 x 1
Post-market 43.19 unch (unch) 16:28 ET
Quote Overview for Fri, Mar 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
41.70
Day High
43.33
Open 42.83
Previous Close 42.99 42.99
Volume 1,519,900 1,519,900
Avg Vol 1,687,930 1,687,930
Stochastic %K 20.63% 20.63%
Weighted Alpha -39.35 -39.35
5-Day Change -2.24 (-4.93%) -2.24 (-4.93%)
52-Week Range 40.53 - 75.71 40.53 - 75.71
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,090,490
  • Shares Outstanding, K 118,411
  • Annual Sales, $ 18,470 K
  • Annual Income, $ -589,530 K
  • EBIT $ -536 M
  • EBITDA $ -527 M
  • 60-Month Beta 0.95
  • Price/Sales 279.65
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 79.13% ( -0.15%)
  • Historical Volatility 57.23%
  • IV Percentile 85%
  • IV Rank 71.32%
  • IV High 97.36% on 05/07/24
  • IV Low 33.79% on 06/03/24
  • Put/Call Vol Ratio 0.05
  • Today's Volume 549
  • Volume Avg (30-Day) 2,392
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 69,667
  • Open Int (30-Day) 68,522

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.41
  • Number of Estimates 12
  • High Estimate -1.22
  • Low Estimate -1.59
  • Prior Year -1.33
  • Growth Rate Est. (year over year) -6.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.70 +3.57%
on 03/28/25
Period Open: 46.00
48.43 -10.82%
on 03/24/25
-2.81 (-6.11%)
since 02/28/25
3-Month
40.53 +6.56%
on 02/12/25
Period Open: 47.36
52.80 -18.20%
on 01/27/25
-4.17 (-8.80%)
since 12/27/24
52-Week
40.53 +6.56%
on 02/12/25
Period Open: 70.11
75.71 -42.95%
on 04/09/24
-26.92 (-38.40%)
since 03/28/24

Most Recent Stories

More News
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

CYTK : 43.19 (+0.47%)
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK : 43.19 (+0.47%)
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo

CYTK : 43.19 (+0.47%)
Cytokinetics to Participate in March Investor Conferences

CYTK : 43.19 (+0.47%)
Cytokinetics: Q4 Earnings Snapshot

Cytokinetics: Q4 Earnings Snapshot

CYTK : 43.19 (+0.47%)
Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update

CYTK : 43.19 (+0.47%)
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK : 43.19 (+0.47%)
Cytokinetics to Announce Fourth Quarter Results on February 27, 2025

CYTK : 43.19 (+0.47%)
Cytokinetics Names Robert E. Landry to Board of Directors

CYTK : 43.19 (+0.47%)
Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CYTK : 43.19 (+0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology...

See More

Key Turning Points

3rd Resistance Point 45.41
2nd Resistance Point 44.37
1st Resistance Point 43.78
Last Price 43.19
1st Support Level 42.15
2nd Support Level 41.11
3rd Support Level 40.52

See More

52-Week High 75.71
Fibonacci 61.8% 62.27
Fibonacci 50% 58.12
Fibonacci 38.2% 53.97
Last Price 43.19
52-Week Low 40.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies